[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-kwf-kankerbestrijding-boost-bridging-obstacles-for-optimal-model-use-via-2026-07":3,"similar-kwf-kankerbestrijding-boost-bridging-obstacles-for-optimal-model-use-via-2026-07":26},{"id":4,"name":5,"funder":6,"budget":7,"budget_min_eur":8,"budget_max_eur":9,"budget_high_priority":10,"duration":11,"deadline":12,"deadline_note":13,"trl":14,"relevance":8,"why_relevant":8,"early_career":10,"consortium":15,"link":16,"first_seen":17,"last_updated":18,"update_note":8,"status":19,"stages":20,"call_frequency":8,"next_call_expected":8,"source_url":16,"created_at":21,"updated_at":22,"eligible_countries":23,"seo_summary":8,"seo_summary_hash":8,"description":25},"kwf-kankerbestrijding-boost-bridging-obstacles-for-optimal-model-use-via-2026-07","BOOST (Bridging Obstacles for Optimal model use via Shared Technical expertise)","KWF Kankerbestrijding","~€150,000 per project",null,150000,false,"6-24 months","2026-07-01T00:00:00.000Z","Deadline inferred from reference to 1 July 2026 cut-off; participating institutes not yet registered must submit registration request at least 6 weeks prior to closing date","3+","No","https:\u002F\u002Fwww.kwf.nl\u002Fen\u002Fforresearchers\u002Ffunding\u002Fboost","2026-04-27T00:00:00.000Z","2026-04-29T00:00:00.000Z","open","Single stage: full-proposal only","2026-04-27T13:58:44.162Z","2026-04-29T04:20:58.422Z",[24],"NL","Open to researchers with an ongoing or recently finished KWF drug research project (start ≥6 months ago, end ≤1.5 years before 1 July 2026). Funds access to clinically relevant preclinical models, technologies and expertise (e.g. NAMs, PDX, organoids, CROs) to improve translational value. Dutch institutions only; commercial partner involvement requires a letter of intent.",{"grants":27},[]]